Variable | Low-dose steroid group | High-dose steroid group | p |
---|---|---|---|
n | 25 | 36 | – |
Age (years ± SD) | 52 ± 19 | 55 ± 14 | 0.60 |
Female | 18 (72.0) | 25 (69.4) | – |
BMI, kg/m2 | 25 ± 5 | 28 ± 6 | <0.05 |
LVEF,  % | 62 [61–71] | 62 [56–65] | 0.19 |
LVEDV, ml | 120 [100–136] | 121 [108–137] | 0.64 |
LVESV, ml | 42 [30–56] | 45 [37–57] | 0.22 |
Epicardial fat, cm2 | 4.7 [2.1–7.5] | 7.2 [4.2–11.1] | <0.01 |
Pericardial fat, cm2 | 8.3 [2.3–18.7] | 18.6 [8.9–38.2] | <0.001 |
CAD | 2/25 (8.0) | 7/36 (19.4) | 0.29 |
Arterial hypertension | 11 (44.0) | 22 (61.1) | 0.09 |
Systolic blood pressure, mmHg | 123 ± 16 | 128 ± 21 | 0.23 |
Diastolic blood pressure, mmHg | 74 ± 9 | 73 ± 10 | 0.81 |
Diabetes | 3 (12.0) | 7 (19.4) | 0.51 |
Hypercholesterolemia | 2 (8.0) | 8 (22.2) | 0.18 |
Total cholesterol, mmol/l | 5.2 ± 3.12 | 5.37 ± 1.19 | 0.64 |
LDL cholesterol, mmol/l | 3.2 ± 1.11 | 3.25 ± 0.98 | 0.88 |
HDL cholesterol, mmol/l | 1.48 ± 0.52 | 1.52 ± 0.48 | 0.77 |
Triglycerides, mmol/l | 4.46 ± 3.28 | 4.53 ± 3.57 | 0.95 |
Smoker | 5 (20.0) | 7 (19.4) | 1.00 |
Positive family history of CAD | 12 (48.0) | 15 (41.7) | 0.79 |
Daily steroid dose at inclusion, mg | 5.0 [3.8–7.5] | 15 [10–28] | 0.46 |
Metabolic syndrome | 0 | 2 (5.5) | 0.51 |